Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program

NCT00569751 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT00569751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00569751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program
Lead sponsor
Boston Scientific Corporation
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2004
Completion date
July 31, 2008
Enrollment
5,016 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, de novo coronary lesions